Pluspunten
Interesting technology, decent benefits, nice coworkers.
Minpunten
No budget for product improvement, new product development, or new equipment, but $6B to buy back stock. Management is using cash to buy back company stock! That's done to drive up stock price so retiring managers can make a windfall on their stock sales. Merger with UTI coincided with stock buybacks. Basically, UTI bought a taxpayer-funded defense contractor and is milking it for its profits while starving it. Raytheon was the ONLY profitable company in the completed merger. Collins Aerospace and P&W were on their knees. R/D funding is non-existent. Poor product yield is baked into the price, so no, nobody cares about product improvement. Just keep pumping out stuff developed 30 years ago. Virtually nobody left who is capable of developing new products.